Market Setup
Week of 2026-04-05: Solana market activity stayed dynamic, with leadership concentrated in a subset of tokens while risk and liquidity conditions varied across categories. Notable movers this week included WIZARD, Clude, JTO, Lost. Volume participation was strongest in PIXEL, VDOR, 2Z, ZBCN, which suggests active rotation and ongoing attention. Risk conditions widened for names such as gork, BioLLM, AUTISM, Pippkin, which reinforces the need for tighter monitoring in fast-moving segments. Attention signals remained elevated around ADULF, ELUN, 49, SETUSHI. Market events over 7 days: 12 positive, 74 negative, 8 neutral signals. Personal/watchlist-aligned events represented 0 signal updates this week. This public report is a high-level research layer; NAVI provides deeper live analysis, alerts, portfolio context, and workflow tools inside the app. Informational only. Not financial advice.
Tokens To Watch
WIZARD (Smoking Wizard) enters the week after a +959.1% 7-day move and roughly $365.2K in daily turnover. CLUDE enters the week after a +767.6% 7-day move and roughly $422.4K in daily turnover. JTO (JITO) enters the week after a +661.6% 7-day move and roughly $563.3K in daily turnover.
Narratives To Watch
PIXEL, Yuri, ERUKA remain the clearest attention leaders, which means narrative follow-through will depend on whether they keep depth as well as social velocity.
Momentum and Risk Setup
GORK carries a higher relative risk shift of +1.0% BIOLLM carries a higher relative risk shift of +1.0%. That makes sizing discipline and waiting for confirmation more important than usual.
Levels or Conditions To Monitor
Watch whether PIXEL and VDOR can hold elevated turnover without liquidity thinning. Sustained volume with stable depth is a better signal than one-session spikes.
What NAVI Is Watching
WIZARD led weekly upside among tracked tokens; validate continuation against liquidity quality before chasing breakouts. PIXEL showed the strongest volume growth signal, which can confirm participation but still requires structure checks. gork showed the steepest risk-profile increase, so sizing and invalidation discipline should be tighter than usual.
